- Corporate Officers - W
- Wiggins Mark C
Insider Trading History of Wiggins Mark C
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Wiggins Mark C since 2006.
This trader's CIK number is 1236540.
At the time of last reporting, Wiggins Mark C was the Chief Business Officer of Tracon Pharmaceuticals, Inc.. (stock ticker symbol TCON).
Also see all insider trading activities at Tracon Pharmaceuticals, Inc..
Note that in the past
WIGGINS MARK C also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Biogen Inc. (BIIB) by Wiggins Mark C
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | BIIB | 0 | $0 | 30,064 | $1,820,335 | 33,014 | $1,131,305 |
| 2007 | BIIB | 0 | $0 | 353,825 | $21,928,411 | 335,757 | $16,608,055 |
| 2006 | BIIB | 0 | $0 | 33,106 | $1,302,990 | 0 | $0 |
Yearly summary of insider trading at Zogenix, Inc. (ZGNX) by Wiggins Mark C
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | ZGNX | 2,500 | $51,195 | 0 | $0 | 0 | $0 |
| 2019 | ZGNX | 0 | $0 | 6,250 | $312,500 | 6,250 | $94,000 |
Yearly summary of insider trading at Tracon Pharmaceuticals, Inc. (TCON) by Wiggins Mark C
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | TCON | 13,000 | $59,622 | 0 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Wiggins Mark C:
1. Biogen Inc. (BIIB)
2. Zogenix, Inc. (ZGNX)
3. Tracon Pharmaceuticals, Inc. (TCON)
Table 1. Insider trading of Biogen Inc. (BIIB) by Wiggins Mark C
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-09-26 | BIIB | Sale | 734 | 50.00 | 36,700 |
| 2008-07-25 | BIIB | Option Ex | 1,603 | 35.37 | 56,698 |
| 2008-07-15 | BIIB | Option Ex | 6,250 | 59.39 | 371,187 |
| 2008-07-15 | BIIB | Sale | 6,250 | 64.00 | 400,000 |
| 2008-02-12 | BIIB | Sale | 4,286 | 60.95 | 261,223 |
| 2008-02-06 | BIIB | Sale | 11,925 | 61.17 | 729,416 |
| 2008-02-06 | BIIB | Option Ex | 18,292 | 22.12 | 404,619 |
| 2007-12-31 | BIIB | Option Ex | 6,869 | 43.50 | 298,801 |
| 2007-12-31 | BIIB | Sale | 6,869 | 57.21 | 392,996 |
| 2007-10-15 | BIIB | Option Ex | 89,645 | 66.31 | 5,944,808 |
| 2007-10-15 | BIIB | Sale | 89,645 | 82.00 | 7,350,890 |
| 2007-09-06 | BIIB | Option Ex | 66,639 | 57.33 | 3,820,613 |
| 2007-09-06 | BIIB | Sale | 66,639 | 65.00 | 4,331,535 |
| 2007-08-27 | BIIB | Sale | 18,750 | 64.00 | 1,200,000 |
| 2007-08-27 | BIIB | Option Ex | 18,750 | 59.39 | 1,113,562 |
| 2007-07-12 | BIIB | Option Ex | 41,128 | 35.21 | 1,448,034 |
| 2007-07-12 | BIIB | Sale | 41,128 | 55.00 | 2,262,040 |
| 2007-07-03 | BIIB | Option Ex | 15,697 | 35.37 | 555,202 |
| 2007-07-02 | BIIB | Sale | 733 | 53.50 | 39,215 |
| 2007-07-03 | BIIB | Sale | 15,697 | 54.00 | 847,638 |
| 2007-06-27 | BIIB | Option Ex | 11,925 | 44.24 | 527,562 |
| 2007-06-27 | BIIB | Sale | 11,925 | 53.00 | 632,072 |
| 2007-06-20 | BIIB | Sale | 5,825 | 51.75 | 301,443 |
| 2007-05-30 | BIIB | Sale | 6,869 | 51.54 | 354,028 |
| 2007-05-30 | BIIB | Option Ex | 6,869 | 43.50 | 298,801 |
| 2007-05-23 | BIIB | Sale | 10,000 | 49.00 | 490,000 |
| 2007-05-23 | BIIB | Option Ex | 10,000 | 35.21 | 352,080 |
| 2007-05-16 | BIIB | Option Ex | 5,000 | 35.37 | 176,850 |
| 2007-05-16 | BIIB | Sale | 5,000 | 46.31 | 231,545 |
| 2007-04-23 | BIIB | Option Ex | 43,737 | 38.03 | 1,663,143 |
| 2007-04-23 | BIIB | Sale | 43,737 | 47.59 | 2,081,575 |
| 2007-04-16 | BIIB | Sale | 5,000 | 45.57 | 227,850 |
| 2007-04-16 | BIIB | Option Ex | 5,000 | 35.37 | 176,850 |
| 2007-03-20 | BIIB | Sale | 5,929 | 44.48 | 263,710 |
| 2007-03-15 | BIIB | Option Ex | 5,000 | 35.37 | 176,850 |
| 2007-03-15 | BIIB | Sale | 5,000 | 44.05 | 220,255 |
| 2007-02-15 | BIIB | Option Ex | 5,000 | 35.37 | 176,850 |
| 2007-02-15 | BIIB | Sale | 5,000 | 50.17 | 250,859 |
| 2007-02-13 | BIIB | Sale | 10,595 | 49.22 | 521,443 |
| 2007-02-06 | BIIB | Option Ex | 6,367 | .00 | 0 |
| 2007-01-16 | BIIB | Option Ex | 5,000 | 35.37 | 176,850 |
| 2007-01-16 | BIIB | Sale | 6,353 | 50.73 | 322,313 |
| 2006-09-19 | BIIB | Sale | 18,186 | 42.76 | 777,687 |
| 2006-01-03 | BIIB | Sale | 14,920 | 35.21 | 525,303 |
Table 2. Insider trading of Zogenix, Inc. (ZGNX) by Wiggins Mark C
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-03-23 | ZGNX | Buy | 2,500 | 20.48 | 51,195 |
| 2019-08-09 | ZGNX | Option Ex | 6,250 | 15.04 | 94,000 |
| 2019-08-09 | ZGNX | Sale | 6,250 | 50.00 | 312,500 |
Table 3. Insider trading of Tracon Pharmaceuticals, Inc. (TCON) by Wiggins Mark C
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-12-29 | TCON | Buy | 1,000 | 10.56 | 10,565 |
| 2020-09-10 | TCON | Buy | 7,000 | 4.14 | 28,952 |
| 2020-01-23 | TCON | Buy | 5,000 | 4.02 | 20,105 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Wiggins Mark C
(Chief Business Officer of Tracon Pharmaceuticals, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.